During the last session, Co-Diagnostics Inc (NASDAQ:CODX)’s traded shares were 0.36 million, with the beta value of the company hitting 1.03. At the end of the trading day, the stock’s price was $0.56, reflecting an intraday gain of 9.01% or $0.05. The 52-week high for the CODX share is $2.23, that puts it down -298.21 from that peak though still a striking 17.86% gain since the share price plummeted to a 52-week low of $0.46. The company’s market capitalization is $17.88M, and the average trade volume was 208.05K shares over the past three months.
Co-Diagnostics Inc (NASDAQ:CODX) trade information
Co-Diagnostics Inc (CODX) registered a 9.01% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 9.01% in intraday trading to $0.56, hitting a weekly high. The stock’s 5-day price performance is 13.13%, and it has moved by -23.24% in 30 days. Based on these gigs, the overall price performance for the year is -52.14%.
The consensus price target of analysts on Wall Street is $6, which implies an increase of 90.67% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $6 and $6 respectively. As a result, CODX is trading at a discount of -971.43% off the target high and -971.43% off the low.
Co-Diagnostics Inc (CODX) estimates and forecasts
In the rating firms’ projections, revenue will decrease -39.21% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 375k as predicted by 1 analyst(s). Meanwhile, a consensus of 1 analyst(s) estimates revenue growth to 400k by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 3.56M and 467.85k respectively. In this case, analysts expect current quarter sales to shrink by -89.45% and then drop by -14.50% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -19.10%. While earnings are projected to return -1.33% in 2025.
CODX Dividends
Co-Diagnostics Inc is due to release its next quarterly earnings in April. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
The next largest institutional holding, with 0.59 million shares, is of RENAISSANCE TECHNOLOGIES LLC’s that is approximately 1.967% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $0.73 million.
Also, the Mutual Funds coming in first place with the largest holdings of Co-Diagnostics Inc (CODX) shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . Data provided on Sep 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 1.28 shares. This amounts to just over 4.01 percent of the company’s overall shares, with a $0.72 million market value. The same data shows that the other fund manager holds slightly less at 444.78, or about 1.39% of the stock, which is worth about $0.25 million.
